The NIH-funded T32 Training Program in Diabetes, Endocrinology and Metabolism at Stanford, directed by Dr. Andrew Hoffman, was renewed for another 5 years in July 2017, allowing continuous training now in its 42nd year. 

The new Stanford Center for Definitive and Curative Medicine will work to turn discoveries into stem cell and gene therapies to aid the millions of people who have genetic diseases.

The Stanford psychiatrist, neuroscientist and bioengineer will be honored for three distinct contributions to the medical field: optogenetics, hydrogel-tissue chemistry and research into depression.

Researchers at the School of Medicine and Lucile Packard Children’s Hospital are testing easier ways for younger children with Type 1 diabetes to get the doses of insulin they need.

A lot has been written here and elsewhere about the unpredictability and deadliness of most forms of pancreatic cancer.